Los Angeles, CA27 Active Studies

Interstitial Lung Disease Clinical Trials in Los Angeles, CA

Find 27 actively recruiting interstitial lung disease clinical trials in Los Angeles, CA. Connect with local research sites and explore new treatment options.

27
Active Trials
21
Sponsors
21,533
Enrolling

Recruiting Interstitial Lung Disease Studies in Los Angeles

About Interstitial Lung Disease Clinical Trials in Los Angeles

Interstitial lung disease is a group of disorders characterized by progressive scarring of lung tissue, leading to breathlessness and reduced oxygen exchange. Causes include autoimmune diseases, environmental exposures, and unknown factors. Treatment includes antifibrotic medications and immunosuppressants.

There are currently 27 interstitial lung disease clinical trials recruiting participants in Los Angeles, CA. These studies are seeking a combined 21,533 participants. Research is being sponsored by Boston Children's Hospital, George Washington University, Duke University and 18 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Interstitial Lung Disease Clinical Trials in Los Angeles — FAQ

Are there interstitial lung disease clinical trials in Los Angeles?

Yes, there are 27 interstitial lung disease clinical trials currently recruiting in Los Angeles, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Los Angeles?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.

Are clinical trials in Los Angeles free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.

What interstitial lung disease treatments are being tested?

The 27 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial lung disease.

Data updated October 19, 2026 from ClinicalTrials.gov